Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-044-8 | CAS number: 68186-64-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Studies on acute oral, dermal or inhalation toxicity do not need to be conducted according to REACH Annex VII and VIII Section 8.5, Column 2 since the test item is classified as skin corrosive and severely eye damaging cat 1 according to CLP.
However, based on available studies on acute oral toxicity with the test item at different compositions, i. e. 40 - 46 % water, the LD50 of the tested substance was > 2000, 5000 or 6700 mg/kg bw in rats. This corresponds to a corrected LD50 of at least greater than 2000 mg/kg bw of the substance registered.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as corrosive to the skin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Supporting studies with aqueous solutions of the registered substance.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as corrosive to the skin
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
Since the test item is classified and labelled as corrosive to skin and eye cat 1 according to CLP, no acute oral toxicity study is conducted.
Supporting studies with aqueous solutions of the test item
A study was conducted in 1987 to assess the acute oral toxicity of the test material (aqueous solution with 45 % water) in the rat according to OECD Guideline No 401. Five male and five female Sprague-Dawley CFY strain rats were used. All animals were dosed once only by gavage with a limit dose of 2000 mg/kg bw. The animals were observed for a period of 14 days. As a result, no mortality occurred and no signs of systemic toxicity were noted. Therefore, the LD50 of the tested material was considered to be >2000 mg/kg bw. Since no systemic toxicity or mortality was observed, derivation of a corrected LD50 is not reasonable based on these data.
A study was conducted in 1986 to assess the acute oral toxicity of the test material (conatining 40 % water) in the rat according to OECD Guideline No 401. Five male and five female Sprague-Dawley CFY strain rats were used.
All animals were dosed once only by gavage with a limit dose of 5000 mg/kg bw. The animals were observed for a period of 14 days. As a result, one male animal was found dead. Hunched posture, lethargy, pilo-erection and a decreased respiratory rate was observed in all animals on the day of dosing. Ptosis was also occasionally observed. All surviving animals continued to show hunched posture, lethargy, pilo-erection and a decreased respiratory rate on day one. All surviving animals appeared normal on day two. Therefore, the LD50 of the test material was considered to be >5000 mg/kg bw. Correspondingly, the corrected LD50 (without water) is considered to be > 3000 mg/kg bw for the test item.
Furthermore, an additional study was conducted in 1979 to assess the acute oral toxicity of the test material containing 46 % water in the rat comparable to OECD Guideline No 401. Five male and five Wistar rats were used per dose group (doses: 0, 5, 6.4, 8, 10 mL/kg bw). An additonal control group received water. All animals were dosed once only by gavage. The animals were observed for a period of 14 days. No mortalitiy was observed in the control group. Deaths were observed in all dose groups and the animals exhibited ruffled fur, pale limbs, hunched posture, lacrimation, diarrhea, lethargy and ataxy was observed. Based on mortality, the LD50 was determined to be 6.75 mL/kg bw (corresponding to 7.115 mg/kg bw.
As the tested material has a higher water content (46%) compared to the substance to be registered, it was concluded that the LD50 value for the registered substance is ca. 3600 mg/kg bw.
In conclusion, acute oral toxicity does not need to be tested with the test item because it is classified as skin and eye corrosive. However, studies are available with aqueous solutions of the test item. Based on the results of these studies, corrected LD50 values would be greater than 2000 mg/kg bw in the rat. Therefore, the substance to be registered does not require classification for acute oral toxicity according to CLP.
Acute dermal toxicity
A study was conducted to assess the toxicity of test item when administered in a single dermal dose to rats at one or more defined dose levels.At first, the range-finding study was performed in one female Han:WISTrat. The starting dose was 200 mg/kg bw. The test item was applied in original form and left in contact with the skin for a 24 hours period. The observation period was three days (treatment day as Day 0 and post treatment period as Day 1 and Day 2). The in-life phase was terminated on Day 2 and the study was stopped, because unexpected corrosive signs were found on the treated skin surface. Moderate to severe erythema and other sign as whitish colouration were observed on Day 1, 1 hour after the patch removal. Severe erythema, open wound, crust and necrosis were detected on Day 2. No death and any systemic toxic sign were found. The body weight loss (approx. 4.2 %) was observed between the treatment day and Day 2. External macroscopic changes as open wound, crust and necrosis were found on the treated area of the animal. The test item could not be classified into any toxicity category and was furthermore classified as corrosive to skin (Cat 1B), therefore no further studies on the acute dermal toxicity have to be conducted. No conclusion regarding classification of the substance for acute dermal toxicity can be drawn based on the available study.
Acute inhalation toxicity
Since the test item is classified and labelled as corrosive to skin and ey cat 1 according to CLP, no acute inhalation toxicity study is conducted.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
There are no
data available with the substance to be registered on acute systemic
toxicity. However,
acute oral toxicity studies are available with aqueous solutions of the
test item. Based on the results of these studies, corrected LD50 values
would be greater than 2000 mg/kg bw in the rat. Therefore, the
registered substance does not require classification for acute oral
toxicity according to Regulation (EC) No 1272/2008 (CLP).
No conclusion can be made for actue inhalation
or dermal toxicity based on the available data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.